Predicting the need for Continuous Positive Airway Pressure (CPAP) or High-flow nasal oxygen (HFNO) in COVID-19 and patient outcome

M. Malik (Redhill, United Kingdom), S. Bax (Redhill, United Kingdom), R. Ahmed (Redhill, United Kingdom), S. Bax (Redhill (Surrey), United Kingdom)

Source: International Congress 2022 – Noninvasive respiratory support in COVID-19: what did we learn?

Session: Noninvasive respiratory support in COVID-19: what did we learn?
Session type: Thematic Poster
Number: 4241

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Malik (Redhill, United Kingdom), S. Bax (Redhill, United Kingdom), R. Ahmed (Redhill, United Kingdom), S. Bax (Redhill (Surrey), United Kingdom). Predicting the need for Continuous Positive Airway Pressure (CPAP) or High-flow nasal oxygen (HFNO) in COVID-19 and patient outcome. 4241

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.